DirectEffect is a volunteer group dedicated exclusively to raising funds for HIV and AIDS research at The Rockefeller University in New York. In contrast with other AIDS charities, DirectEffect contributes every dollar it raises to basic and clinical investigations aimed at developing effective HIV vaccines and improving AIDS treatment. These studies are conducted within the Christopher H. Browne Center for Immunology and Immune Diseases, an interactive consortium of world-class
immunology labs at Rockefeller. The University's prominence in HIV studies is further enhanced through its affiliation with the renowned Aaron Diamond AIDS Research Center for the City of New York. With strengths in multiple areas of scientific inquiry, Rockefeller scientists are uniquely positioned to develop the new medical tools that will be needed to stem the global AIDS epidemic. DirectEffect plays an essential role in these efforts through its support of outstanding and innovative research
on HIV and AIDS.
Dendritic cell receptor may be the key to an HIV vaccine. Read more »
Researchers track down the location of HIV-1 assembly in human cells. Read more »
HIV-1 virus kills immune cells in the gut that may never bounce back. Read more »
Rockefeller researchers receive Gates Foundation grant for HIV vaccine research. Read more »
Friday, October 3, 2008 Newly identified cells make fat The discovery of an important fat precursor cell may explain how changes in the numbers of fat cells might increase and lead to obesity.